These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 508558)

  • 1. Plasma Xa inhibitory activities and plasma concentrations of norgestrel and ethinyloestradiol in women on oral contraceptive steroids.
    Back DJ; Bates M; Burke MW; Breckenridge AM; Crawford FE; MacIver M; Orme ML; Rowe PH; Smith E; Webster S
    Br J Clin Pharmacol; 1979 Nov; 8(5):505-6. PubMed ID: 508558
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral contraceptive steroid plasma concentrations in smokers and non-smokers.
    Crawford FE; Back DJ; Orme ML; Breckenridge AM
    Br Med J (Clin Res Ed); 1981 Jun; 282(6279):1829-30. PubMed ID: 6786637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tobacco smoking and oral contraceptive use on theophylline disposition.
    Gardner MJ; Tornatore KM; Jusko WJ; Kanarkowski R
    Br J Clin Pharmacol; 1983 Sep; 16(3):271-80. PubMed ID: 6626419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of contraceptive steroids in patients with cystic fibrosis.
    Stead RJ; Grimmer SF; Rogers SM; Back DJ; Orme ML; Hodson ME; Batten JC
    Thorax; 1987 Jan; 42(1):59-64. PubMed ID: 3112991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of ethinyloestradiol with ascorbic acid in man.
    Back DJ; Breckenridge AM; MacIver M; Orme ML; Purba H; Rowe PH
    Br Med J (Clin Res Ed); 1981 May; 282(6275):1516. PubMed ID: 6786543
    [No Abstract]   [Full Text] [Related]  

  • 7. Elevated caffeine and ethynylestradiol blood levels in hypertensive oral contraceptive users.
    Ahluwalia BS; Verma PS; Greer L; Khanna KL; Crocker CL
    Contraception; 1977 Apr; 15(4):465-71. PubMed ID: 880820
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of environmental chemicals on drug therapy in humans: studies with contraceptive steroids.
    Breckenridge AM; Back DJ; Cross K; Crawford F; MacIver M; Orme ML; Rowe PH; Smith E
    Ciba Found Symp; 1980; 76():289-306. PubMed ID: 6906266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inter- and intra-individual variability of pharmacokinetic parameters for contraceptive steroids].
    Carol W; Klinger G; Jäger R; Kasch R; Michels W
    Zentralbl Gynakol; 1991; 113(13):783-7. PubMed ID: 1927130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of oral contraceptive on alpha I-antitrypsin activity.
    Kishore N; Rizvi V; Kishore N; Sharma BB
    J Obstet Gynaecol India; 1979 Apr; 29(2):259-60. PubMed ID: 12335890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of an oral contraceptive (ethinylestradiol/D-norgestrel) on growth hormone and insulin secretion].
    Hausmann L; Goebel KM; Zehner J
    Schweiz Med Wochenschr; 1976 Oct; 106(43):1470-4. PubMed ID: 1013665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in hormonal contraception. A new micro-pll with especially low hormone effect].
    Gynakologe; 1994 Apr; 27(2 Suppl):1-12. PubMed ID: 9131064
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative metabolism of 17alpha-ethynyl steroids used in oral contraceptives.
    Ranney RE
    J Toxicol Environ Health; 1977 Sep; 3(1-2):139-66. PubMed ID: 411940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipids and blood coagulation studies in women using steroidal hormones for contraception.
    Hashmi JA; Kazi AB; Kazi A; Ali N
    J Pak Med Assoc (1951); 1972 Aug; 22(8):218-25. PubMed ID: 12305803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estrogens. Contraceptive therapy].
    Sojo-Aranda I; Cortés-Gallegos V
    Ginecol Obstet Mex; 1995 Jan; 63():46-9. PubMed ID: 7896159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the contraceptive pill on sedative responses to clonidine and apomorphine in normal women.
    Chalmers JS; Fulli-Lemaire I; Cowen PJ
    Psychol Med; 1985 May; 15(2):363-7. PubMed ID: 2991959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Action of hormonal contraceptives on the coagulation system and some of its inhibitors.
    Misz M; Beck P
    Acta Med Hung; 1986; 43(3):301-10. PubMed ID: 2438639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate.
    Schmitt-Hoffmann AH; Roos B; Sauer J; Schleimer M; Schoetzau A; Leese PT; Weidekamm E; Maares J
    Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():4-11. PubMed ID: 21443598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic Effects of a Commonly Used Combined Hormonal Oral Contraceptive in Women With and Without Polycystic Ovary Syndrome.
    Adeniji AA; Essah PA; Nestler JE; Cheang KI
    J Womens Health (Larchmt); 2016 Jun; 25(6):638-45. PubMed ID: 26871978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.